Life SciencesLiability
Contact
SpecialtyStandard / Universal

USP 800 Hazardous Drug Handling

What this clause says

Where Vendor handles drugs designated hazardous by NIOSH, Vendor shall maintain compliance with USP General Chapter <800> covering containment, ventilation, PPE, and waste disposal, with documentation available for Sponsor audit.

What this means in plain English

USP 800 governs handling of hazardous drugs (NIOSH list) - chemotherapy, hormones, antivirals, immunosuppressants. Compliance affects facility design, PPE, environmental controls, and training, with insurance implications for workers comp, products, and pollution.

What it means for a CDMO program

Pharmacies handling hazardous drugs without USP 800 compliance face workers comp surcharges, products liability exclusions, and potential pollution liability gaps. State boards have made USP 800 enforcement a focus since 2022.

How this evaluates

The Decoder applies these rules in order; the first match wins.

  • usp800 › applies is set → Borderline: Hazardous drugs handled - USP 800 documentation must be current.

See this in your MSA

Map this clause against your sponsor MSA.

Run the Decoder

Related clauses

Common questions about this clause

Questions about specialty

USP 800 Hazardous Drug Handling - common questions

Which drugs trigger USP 800?

The NIOSH hazardous-drug list - most chemotherapy agents, certain hormones, antivirals, and immunosuppressants. NIOSH publishes the list and updates it periodically.

Do I need a separate hazardous-drug compounding room?

Yes - USP 800 requires a negative-pressure containment area with proper ventilation, separate from non-hazardous compounding spaces.

What insurance lines does USP 800 affect?

Workers comp (occupational hazardous-drug exposure), products liability (cross-contamination claims), and pollution liability (waste-stream and accidental-release exposures).